Updates on the treatment of acute promyelocytic leukemia.
Tallman
Martin S
MS
Division of Hematology and Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
D018943:Anthracyclines / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D001565:Benzoates / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D006470:Hemorrhage / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D015255:Idarubicin / Q000008:administration & dosage; D015473:Leukemia, Promyelocytic, Acute / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D013764:Tetrahydronaphthalenes / Q000008:administration & dosage; D014212:Tretinoin / Q000008:administration & dosage
D018943:Anthracyclines; D001565:Benzoates; D013764:Tetrahydronaphthalenes; D003561:Cytarabine; C061133:tamibarotene; D014212:Tretinoin; D015255:Idarubicin; D003630:Daunorubicin